837.57 -5.00 (-0.59%)
5.9M XNYS Volume
XNYS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 839.29 per share. | 17 Mar 2025 | 14 | 54,832 (0%) | 0% | 839.3 | 11,750 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 17 Mar 2025 | 6 | 2,556 (0%) | 0% | 826.3 | 4,958 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 17 Mar 2025 | 12 | 72,827 (0%) | 0% | 826.4 | 9,917 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 872.53 per share. | 17 Mar 2025 | 17 | 16,276 (0%) | 0% | 872.5 | 14,833 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 17 Mar 2025 | 12 | 1,918 (0%) | 0% | 826.4 | 9,917 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 818.24 per share. | 13 Mar 2025 | 1,000 | 5,839 (0%) | 0% | 818.2 | 818,240 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,837 | 41,008 (0%) | 0% | 0 | Common Stock | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,837 | 0 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 920.87 per share. | 01 Mar 2025 | 1,260 | 39,748 (0%) | 0% | 920.9 | 1,160,293 | Common Stock |
Eric Dozier | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 920.81 per share. | 01 Mar 2025 | 1,066 | 9,838 (0%) | 0% | 920.8 | 981,587 | Common Stock |
Eric Dozier | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,403 | 0 | - | - | Restricted Stock Unit | |
Eric Dozier | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,403 | 10,905 (0%) | 0% | 0 | Common Stock | |
Eric Dozier | EVP, Chief People Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 460 | 8,502 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 991.60 per share. | 18 Feb 2025 | 5 | 2,545 (0%) | 0% | 991.6 | 4,958 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 901.55 per share. | 18 Feb 2025 | 11 | 72,683 (0%) | 0% | 901.5 | 9,917 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 872.53 per share. | 18 Feb 2025 | 17 | 16,228 (0%) | 0% | 872.5 | 14,833 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 901.55 per share. | 18 Feb 2025 | 11 | 1,903 (0%) | 0% | 901.5 | 9,917 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 903.85 per share. | 18 Feb 2025 | 13 | 54,719 (0%) | 0% | 903.8 | 11,750 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,572 | 3,572 | - | - | Restricted Stock Unit | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 868.99 per share. | 10 Feb 2025 | 6,828 | 74,209 (0%) | 0% | 869.0 | 5,933,469 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 31,932 | 31,932 | - | - | Restricted Stock Unit | |
David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 868.89 per share. | 10 Feb 2025 | 55,131 | 539,613 (0%) | 0% | 868.9 | 47,902,710 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 869.30 per share. | 10 Feb 2025 | 1,359 | 6,839 (0%) | 0% | 869.3 | 1,181,381 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 216 | 216 | - | - | Restricted Stock Unit | |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Grant, award, or other acquisition of securities at price $ 869.00 per share. | 10 Feb 2025 | 6,103 | 19,561 (0%) | 0% | 869.0 | 5,303,491 | Common Stock |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 4,108 | 4,108 | - | - | Restricted Stock Unit | |
Anat Hakim | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 868.96 per share. | 10 Feb 2025 | 10,320 | 28,837 (0%) | 0% | 869.0 | 8,967,672 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 6,700 | 6,700 | - | - | Restricted Stock Unit | |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Sale of securities on an exchange or to another person at price $ 862.69 per share. | 10 Feb 2025 | 3,950 | 118,938 (0%) | 0% | 862.7 | 3,407,626 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Grant, award, or other acquisition of securities at price $ 868.91 per share. | 10 Feb 2025 | 18,771 | 136,660 (0%) | 0% | 868.9 | 16,310,400 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Sale of securities on an exchange or to another person at price $ 865.76 per share. | 10 Feb 2025 | 710 | 117,888 (0%) | 0% | 865.8 | 614,690 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Sale of securities on an exchange or to another person at price $ 863.97 per share. | 10 Feb 2025 | 340 | 118,598 (0%) | 0% | 864.0 | 293,750 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 12,684 | 12,684 | - | - | Restricted Stock Unit | |
Lucas Montarce | EVP & CFO | Grant, award, or other acquisition of securities at price $ 869.16 per share. | 10 Feb 2025 | 2,895 | 13,969 (0%) | 0% | 869.2 | 2,516,217 | Common Stock |
Patrik Jonsson | EVP&Pres, CardMetHlth, LLY USA | Grant, award, or other acquisition of securities at price $ 868.94 per share. | 10 Feb 2025 | 7,170 | 53,650 (0%) | 0% | 868.9 | 6,230,302 | Common Stock |
Patrik Jonsson | EVP&Pres, CardMetHlth, LLY USA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,930 | 3,930 | - | - | Restricted Stock Unit | |
Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,394 | 3,394 | - | - | Restricted Stock Unit | |
Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 868.92 per share. | 10 Feb 2025 | 7,123 | 28,759 (0%) | 0% | 868.9 | 6,189,335 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Grant, award, or other acquisition of securities at price $ 868.90 per share. | 10 Feb 2025 | 5,974 | 38,171 (0%) | 0% | 868.9 | 5,190,812 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,572 | 3,572 | - | - | Restricted Stock Unit | |
Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,752 | 3,752 | - | - | Restricted Stock Unit | |
Diogo Rau | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 868.91 per share. | 10 Feb 2025 | 6,815 | 19,718 (0%) | 0% | 868.9 | 5,921,593 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Grant, award, or other acquisition of securities at price $ 869.38 per share. | 10 Feb 2025 | 919 | 8,962 (0%) | 0% | 869.4 | 798,957 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,858 | 2,858 | - | - | Restricted Stock Unit | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 0 | - | - | Restricted Stock Unit | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.14 per share. | 01 Feb 2025 | 1,457 | 67,380 (0%) | 0% | 811.1 | 1,181,826 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 68,838 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 26,561 | 496,385 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.11 per share. | 01 Feb 2025 | 11,903 | 484,481 (0%) | 0% | 811.1 | 9,654,604 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 26,561 | 0 | - | - | Restricted Stock Unit | |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,023 | 14,868 (0%) | 0% | 0 | Common Stock | |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.56 per share. | 01 Feb 2025 | 1,409 | 13,458 (0%) | 0% | 811.6 | 1,143,492 | Common Stock |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,023 | 0 | - | - | Restricted Stock Unit | |
Anat Hakim | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 4,904 | 20,683 (0%) | 0% | 0 | Common Stock | |
Anat Hakim | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 4,904 | 0 | - | - | Restricted Stock Unit | |
Anat Hakim | EVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.25 per share. | 01 Feb 2025 | 2,166 | 18,516 (0%) | 0% | 811.3 | 1,757,169 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 8,989 | 0 | - | - | Restricted Stock Unit | |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.21 per share. | 01 Feb 2025 | 4,003 | 122,888 (0%) | 0% | 811.2 | 3,247,272 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 8,989 | 126,892 (0%) | 0% | 0 | Common Stock | |
Patrik Jonsson | EVP&Pres, CardMetHlth, LLY USA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,433 | 0 | - | - | Restricted Stock Unit | |
Patrik Jonsson | EVP&Pres, CardMetHlth, LLY USA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,433 | 48,016 (0%) | 0% | 0 | Common Stock | |
Patrik Jonsson | EVP&Pres, CardMetHlth, LLY USA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.53 per share. | 01 Feb 2025 | 1,535 | 46,480 (0%) | 0% | 811.5 | 1,245,705 | Common Stock |
Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 23,071 (0%) | 0% | 0 | Common Stock | |
Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 0 | - | - | Restricted Stock Unit | |
Ilya Yuffa | EVP & President, LLY Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.29 per share. | 01 Feb 2025 | 1,434 | 21,636 (0%) | 0% | 811.3 | 1,163,394 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.45 per share. | 01 Feb 2025 | 1,281 | 32,197 (0%) | 0% | 811.4 | 1,039,466 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,861 | 0 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,861 | 33,479 (0%) | 0% | 0 | Common Stock | |
Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.24 per share. | 01 Feb 2025 | 1,466 | 12,903 (0%) | 0% | 811.2 | 1,189,282 | Common Stock |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 0 | - | - | Restricted Stock Unit | |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 14,370 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.33 per share. | 21 Jan 2025 | 6 | 2,539 (0%) | 0% | 826.3 | 4,958 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 762.77 per share. | 21 Jan 2025 | 13 | 72,671 (0%) | 0% | 762.8 | 9,916 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 780.74 per share. | 21 Jan 2025 | 19 | 16,211 (0%) | 0% | 780.7 | 14,834 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 762.77 per share. | 21 Jan 2025 | 13 | 1,892 (0%) | 0% | 762.8 | 9,916 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 783.33 per share. | 21 Jan 2025 | 15 | 54,705 (0%) | 0% | 783.3 | 11,750 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 16 Dec 2024 | 12 | 2,532 (0%) | 0% | 826.4 | 9,917 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 780.74 per share. | 16 Dec 2024 | 19 | 16,191 (0%) | 0% | 780.7 | 14,834 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 826.42 per share. | 16 Dec 2024 | 12 | 1,878 (0%) | 0% | 826.4 | 9,917 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 783.33 per share. | 16 Dec 2024 | 15 | 54,689 (0%) | 0% | 783.3 | 11,750 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 805.58 per share. | 16 Dec 2024 | 12 | 3,032 (0%) | 0% | 805.6 | 9,667 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 2,516 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 762.85 per share. | 18 Nov 2024 | 13 | 2,214 (0%) | 0% | 762.8 | 9,917 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 728.40 per share. | 18 Nov 2024 | 320 | 72,540 (0%) | 0% | 728.4 | 233,089 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 741.65 per share. | 18 Nov 2024 | 20 | 15,844 (0%) | 0% | 741.7 | 14,833 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 16,146 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 762.85 per share. | 18 Nov 2024 | 13 | 1,561 (0%) | 0% | 762.8 | 9,917 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 1,864 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 54,586 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 734.38 per share. | 18 Nov 2024 | 16 | 54,283 (0%) | 0% | 734.4 | 11,750 | Common Stock |
Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 23,118 (0%) | 0% | 728.5 | 220,000 | Common Stock |
William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 21,464 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Jamere Jackson | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 9,153 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 743.62 per share. | 18 Nov 2024 | 13 | 2,712 (0%) | 0% | 743.6 | 9,667 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 3,015 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Karen Walker | Director | Grant, award, or other acquisition of securities at price $ 728.48 per share. | 18 Nov 2024 | 302 | 6,248 (0%) | 0% | 728.5 | 220,000 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 803.38 per share. | 08 Nov 2024 | 900 | 5,480 (0%) | 0% | 803.4 | 723,042 | Common Stock |
Lucas Montarce | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,074 | 11,541 (0%) | 0% | 0 | Common Stock | |
Lucas Montarce | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,074 | 0 | - | - | Restricted Stock Unit | |
Lucas Montarce | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.27 per share. | 01 Nov 2024 | 467 | 11,073 (0%) | 0% | 819.3 | 382,601 | Common Stock |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,687 | 31,369 (0%) | 0% | 0 | Common Stock | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,687 | 0 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.80 per share. | 01 Nov 2024 | 750 | 30,618 (0%) | 0% | 819.8 | 614,852 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.41 per share. | 01 Nov 2024 | 681 | 8,042 (0%) | 0% | 819.4 | 558,021 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,534 | 0 | - | - | Restricted Stock Unit | |
Eric Dozier | EVP, HR & Diversity | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,534 | 8,724 (0%) | 0% | 0 | Common Stock | |
Jacob S. Van Naarden | EVP & Pres., Lilly Oncology | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2024 | 4,302 | 11,845 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 906.09 per share. | 21 Oct 2024 | 11 | 2,201 (0%) | 0% | 906.1 | 9,967 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 906.12 per share. | 21 Oct 2024 | 16 | 15,825 (0%) | 0% | 906.1 | 14,498 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 906.09 per share. | 21 Oct 2024 | 11 | 1,548 (0%) | 0% | 906.1 | 9,967 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 906.15 per share. | 21 Oct 2024 | 13 | 54,267 (0%) | 0% | 906.2 | 11,780 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 906.09 per share. | 21 Oct 2024 | 11 | 2,699 (0%) | 0% | 906.1 | 9,967 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 923.55 per share. | 16 Sep 2024 | 11 | 2,190 (0%) | 0% | 923.5 | 10,159 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 923.56 per share. | 16 Sep 2024 | 16 | 15,809 (0%) | 0% | 923.6 | 14,777 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 923.55 per share. | 16 Sep 2024 | 11 | 1,537 (0%) | 0% | 923.5 | 10,159 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 923.54 per share. | 16 Sep 2024 | 13 | 54,254 (0%) | 0% | 923.5 | 12,006 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 923.50 per share. | 16 Sep 2024 | 10 | 2,688 (0%) | 0% | 923.5 | 9,235 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Sep 2024 | 111 | 123,627 (0%) | 0% | 0 | Common Stock | |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Sep 2024 | 5,724 | 117,903 (0%) | 0% | 0 | Common Stock | |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 950.00 per share. | 26 Aug 2024 | 750 | 6,380 (0%) | 0% | 950 | 712,500 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Aug 2024 | 13,727 | 469,824 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 921.82 per share. | 19 Aug 2024 | 11 | 2,176 (0%) | 0% | 921.8 | 10,140 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 921.81 per share. | 19 Aug 2024 | 16 | 15,770 (0%) | 0% | 921.8 | 14,749 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 921.82 per share. | 19 Aug 2024 | 11 | 1,524 (0%) | 0% | 921.8 | 10,140 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 921.85 per share. | 19 Aug 2024 | 13 | 54,163 (0%) | 0% | 921.8 | 11,984 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 921.80 per share. | 19 Aug 2024 | 10 | 2,674 (0%) | 0% | 921.8 | 9,218 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 14,700 | 15,779 (0%) | 0% | 0 | Common Stock | |
Melissa Seymour | EVP, Global Quality | 01 Aug 2024 | 2,885 | 2,885 | - | - | Restricted Stock Unit | ||
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 10 | 2,165 (0%) | 0% | 950.5 | 9,505 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 950.44 per share. | 15 Jul 2024 | 16 | 15,754 (0%) | 0% | 950.4 | 15,207 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 10 | 1,513 (0%) | 0% | 950.5 | 9,505 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 12 | 54,150 (0%) | 0% | 950.5 | 11,406 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 950.50 per share. | 15 Jul 2024 | 10 | 2,664 (0%) | 0% | 950.5 | 9,505 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 11 | 2,155 (0%) | 0% | 885 | 9,735 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 17 | 15,738 (0%) | 0% | 885 | 15,045 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 11 | 1,503 (0%) | 0% | 885 | 9,735 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 13 | 54,138 (0%) | 0% | 885 | 11,505 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 885.00 per share. | 17 Jun 2024 | 11 | 2,654 (0%) | 0% | 885 | 9,735 | Common Stock |
Johna L. Norton | EVP, Global Quality | 03 Jun 2024 | 7,056 | 25,428 (0%) | 0% | 819.4 | 5,781,545 | Common Stock | |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 819.47 per share. | 03 Jun 2024 | 750 | 7,130 (0%) | 0% | 819.5 | 614,603 | Common Stock |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 6,300 | 14,146 (0%) | 0% | 0 | Common Stock | |
Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 820.34 per share. | 01 Jun 2024 | 3,045 | 11,101 (0%) | 0% | 820.3 | 2,497,935 | Common Stock |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 6,300 | 0 | - | - | Restricted Stock Unit | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 783.15 per share. | 20 May 2024 | 13 | 2,141 (0%) | 0% | 783.2 | 10,181 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 783.16 per share. | 20 May 2024 | 19 | 15,697 (0%) | 0% | 783.2 | 14,880 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 783.15 per share. | 20 May 2024 | 13 | 1,490 (0%) | 0% | 783.2 | 10,181 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 783.20 per share. | 20 May 2024 | 15 | 54,044 (0%) | 0% | 783.2 | 11,748 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 783.17 per share. | 20 May 2024 | 12 | 2,639 (0%) | 0% | 783.2 | 9,398 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 750.75 per share. | 15 Apr 2024 | 20 | 15,678 (0%) | 0% | 750.8 | 15,015 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 750.77 per share. | 15 Apr 2024 | 13 | 1,477 (0%) | 0% | 750.8 | 9,760 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 750.75 per share. | 15 Apr 2024 | 16 | 54,029 (0%) | 0% | 750.8 | 12,012 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 750.77 per share. | 15 Apr 2024 | 13 | 2,128 (0%) | 0% | 750.8 | 9,760 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 750.77 per share. | 15 Apr 2024 | 13 | 2,627 (0%) | 0% | 750.8 | 9,760 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 762.69 per share. | 18 Mar 2024 | 13 | 1,464 (0%) | 0% | 762.7 | 9,915 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 762.69 per share. | 18 Mar 2024 | 13 | 2,115 (0%) | 0% | 762.7 | 9,915 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 762.68 per share. | 18 Mar 2024 | 19 | 15,658 (0%) | 0% | 762.7 | 14,491 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 762.67 per share. | 18 Mar 2024 | 15 | 54,013 (0%) | 0% | 762.7 | 11,440 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 762.69 per share. | 18 Mar 2024 | 13 | 2,614 (0%) | 0% | 762.7 | 9,915 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 755.65 per share. | 20 Feb 2024 | 20 | 15,612 (0%) | 0% | 755.7 | 15,113 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 13 | 2,098 (0%) | 0% | 755.7 | 9,824 | Common Stock |
Johnson H. Kimberly | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 13 | 2,597 (0%) | 0% | 755.7 | 9,824 | Common Stock |
Lynne Mary Hedley | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 13 | 1,449 (0%) | 0% | 755.7 | 9,824 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 755.69 per share. | 20 Feb 2024 | 16 | 53,906 (0%) | 0% | 755.7 | 12,091 | Common Stock |
Weems Alonzo | EVP, ERM & CECO | 12 Feb 2024 | 951 | 7,951 (0%) | 0% | 737.3 | 701,134 | Common Stock | |
Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,269 | 3,269 | - | - | Restricted Stock Unit | |
Yuffa Ilya | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 4,790 | 19,802 (0%) | 0% | 737.3 | 3,531,475 | Common Stock |
Hakim Anat | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 5,815 | 30,479 (0%) | 0% | 737.3 | 4,287,167 | Common Stock |
Jonsson Patrik | EVP&Pres, LLY Dia&Obe, LLY USA | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 5,362 | 44,583 (0%) | 0% | 737.3 | 3,953,188 | Common Stock |
Rau Diogo | EVP & CIDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,269 | 3,269 | - | - | Restricted Stock Unit | |
Hakim Anat | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 4,904 | 4,904 | - | - | Restricted Stock Unit | |
Donald Zakrowski A. | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 1,254 | 8,630 (0%) | 0% | 737.3 | 924,524 | Common Stock |
Ricks A. David | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 38,392 | 479,250 (0%) | 0% | 737.3 | 28,304,886 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 408 | 5,854 (0%) | 0% | 0 | Common Stock | |
Nobles Anne | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,269 | 3,269 | - | - | Restricted Stock Unit | |
Patrik Jonsson | EVP&Pres, LLY Dia&Obe, LLY USA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,433 | 3,433 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 2,821 | 29,682 (0%) | 0% | 737.3 | 2,079,810 | Common Stock |
Norton Johna L. | EVP, Global Quality | 12 Feb 2024 | 1,668 | 32,484 (0%) | 0% | 737.3 | 1,229,750 | Common Stock | |
S. Van Naarden Jacob | EVP & Pres., Loxo@Lilly | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 2,369 | 16,147 (0%) | 0% | 737.3 | 1,746,569 | Common Stock |
David Ricks A. | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 26,561 | 26,561 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 2,861 | 2,861 | - | - | Restricted Stock Unit | |
Weems Alonzo | EVP, ERM & CECO | 12 Feb 2024 | 980 | 980 | - | - | Restricted Stock Unit | ||
Johna Norton L. | EVP, Global Quality | 12 Feb 2024 | 1,308 | 1,308 | - | - | Restricted Stock Unit | ||
Eric Dozier | EVP, HR & Diversity | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 1,336 | 7,190 (0%) | 0% | 737.3 | 984,979 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 5,363 | 65,569 (0%) | 0% | 737.3 | 3,953,925 | Common Stock |
Van Naarden S. Jacob | EVP & Pres., Loxo@Lilly | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,023 | 3,023 | - | - | Restricted Stock Unit | |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 753.60 per share. | 12 Feb 2024 | 750 | 7,880 (0%) | 0% | 753.6 | 565,200 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 184 | 184 | - | - | Restricted Stock Unit | |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 186 | 186 | - | - | Restricted Stock Unit | |
Ricks A. David | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 956 | 440,858 (0%) | 0% | 0 | Common Stock | |
L. Johna Norton | EVP, Global Quality | 01 Feb 2024 | 1,268 | 0 | - | - | Restricted Stock Unit | ||
Patrik Jonsson | EVP&Pres, LLY Dia&Obe, LLY USA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,844 | 39,221 (0%) | 0% | 645.6 | 1,190,505 | Common Stock |
Daniel M. Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,941 | 115,262 (0%) | 0% | 0 | Common Stock | |
Van Naarden S. Jacob | EVP & Pres., Loxo@Lilly | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,618 | 0 | - | - | Restricted Stock Unit | |
Ilya Yuffa | EVP & President, LLY Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,664 | 15,012 (0%) | 0% | 645.6 | 1,074,295 | Common Stock |
Jacob S. Van Naarden | EVP & Pres., Loxo@Lilly | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,618 | 15,463 (0%) | 0% | 0 | Common Stock | |
Johna L. Norton | EVP, Global Quality | 01 Feb 2024 | 566 | 30,816 (0%) | 0% | 645.6 | 365,415 | Common Stock | |
Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,702 | 0 | - | - | Restricted Stock Unit | |
Jonsson Patrik | EVP&Pres, LLY Dia&Obe, LLY USA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,124 | 0 | - | - | Restricted Stock Unit | |
Norton Johna L. | EVP, Global Quality | 01 Feb 2024 | 1,268 | 31,382 (0%) | 0% | 0 | Common Stock | ||
Skovronsky Daniel M. | EVP, CSO & Pres. LRL & LLY Imm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,941 | 0 | - | - | Restricted Stock Unit | |
Nobles Anne | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,124 | 0 | - | - | Restricted Stock Unit | |
Hakim Anat | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,442 | 26,631 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 29,611 | 455,054 (0%) | 0% | 0 | Common Stock | |
Ricks A. David | Director, President, Chair, and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 13,240 | 441,814 (0%) | 0% | 645.6 | 8,547,876 | Common Stock |
Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,702 | 16,676 (0%) | 0% | 0 | Common Stock | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,844 | 60,206 (0%) | 0% | 645.6 | 1,190,505 | Common Stock |
Daniel Skovronsky M. | EVP, CSO & Pres. LRL & LLY Imm | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 4,434 | 110,828 (0%) | 0% | 645.6 | 2,862,635 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,124 | 62,050 (0%) | 0% | 0 | Common Stock | |
Hakim Anat | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,442 | 0 | - | - | Restricted Stock Unit | |
Anat Hakim | EVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,967 | 24,664 (0%) | 0% | 645.6 | 1,269,915 | Common Stock |
Jonsson Patrik | EVP&Pres, LLY Dia&Obe, LLY USA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,124 | 41,065 (0%) | 0% | 0 | Common Stock | |
Ricks A. David | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 29,611 | 0 | - | - | Restricted Stock Unit | |
Jacob Van Naarden S. | EVP & Pres., Loxo@Lilly | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,685 | 13,778 (0%) | 0% | 645.6 | 1,087,853 | Common Stock |
R. Luciano Juan | Director | Grant, award, or other acquisition of securities at price $ 634.57 per share. | 16 Jan 2024 | 23 | 15,592 (0%) | 0% | 634.6 | 14,595 | Common Stock |
Hedley Mary Lynne | Director | Grant, award, or other acquisition of securities at price $ 634.56 per share. | 16 Jan 2024 | 16 | 1,437 (0%) | 0% | 634.6 | 10,153 | Common Stock |
Alvarez Ralph | Director | Grant, award, or other acquisition of securities at price $ 634.58 per share. | 16 Jan 2024 | 19 | 53,891 (0%) | 0% | 634.6 | 12,057 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 634.56 per share. | 16 Jan 2024 | 16 | 2,085 (0%) | 0% | 634.6 | 10,153 | Common Stock |
H. Kimberly Johnson | Director | Grant, award, or other acquisition of securities at price $ 634.60 per share. | 16 Jan 2024 | 15 | 2,584 (0%) | 0% | 634.6 | 9,519 | Common Stock |
Jon Fyrwald Erik | Director | Grant, award, or other acquisition of securities at price $ 579.76 per share. | 18 Dec 2023 | 17 | 71,886 (0%) | 0% | 579.8 | 9,856 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 579.76 per share. | 18 Dec 2023 | 17 | 2,569 (0%) | 0% | 579.8 | 9,856 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 579.78 per share. | 18 Dec 2023 | 9 | 2,069 (0%) | 0% | 579.8 | 5,218 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 579.76 per share. | 18 Dec 2023 | 17 | 1,421 (0%) | 0% | 579.8 | 9,856 | Common Stock |
Alvarez Ralph | Director | Grant, award, or other acquisition of securities at price $ 579.75 per share. | 18 Dec 2023 | 20 | 53,872 (0%) | 0% | 579.8 | 11,595 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 579.76 per share. | 18 Dec 2023 | 25 | 15,569 (0%) | 0% | 579.8 | 14,494 | Common Stock |
A. Zakrowski Donald | SVP, Finance, & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 4,810 | 0 | - | - | Restricted Stock Unit | |
Zakrowski Donald A. | SVP, Finance, & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 4,810 | 9,518 (0%) | 0% | 0 | Common Stock | |
Zakrowski A. Donald | SVP, Finance, & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 591.04 per share. | 01 Dec 2023 | 2,142 | 7,376 (0%) | 0% | 591.0 | 1,266,008 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 597.62 per share. | 20 Nov 2023 | 8 | 1,722 (0%) | 0% | 597.6 | 4,781 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 2,057 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 597.59 per share. | 20 Nov 2023 | 17 | 71,401 (0%) | 0% | 597.6 | 10,159 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 71,736 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 597.58 per share. | 20 Nov 2023 | 24 | 15,180 (0%) | 0% | 597.6 | 14,342 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 15,515 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 1,403 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 597.59 per share. | 20 Nov 2023 | 17 | 1,068 (0%) | 0% | 597.6 | 10,159 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 53,751 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 597.58 per share. | 20 Nov 2023 | 19 | 53,416 (0%) | 0% | 597.6 | 11,354 | Common Stock |
Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 22,667 (0%) | 0% | 597.6 | 200,196 | Common Stock |
William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 21,026 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 16,593 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Jamere Jackson | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 8,794 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 597.62 per share. | 20 Nov 2023 | 16 | 2,213 (0%) | 0% | 597.6 | 9,562 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 2,548 (0%) | 0% | 597.6 | 200,196 | Common Stock |
Karen Walker | Director | Grant, award, or other acquisition of securities at price $ 597.60 per share. | 20 Nov 2023 | 335 | 5,909 (0%) | 0% | 597.6 | 200,196 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2023 | 15,000 | 425,443 (0%) | 0% | 0 | Common Stock | |
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2023 | 17 | 105,321 (0%) | 0% | 0 | Common Stock | |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 571.10 per share. | 06 Nov 2023 | 670 | 4,708 (0%) | 0% | 571.1 | 382,637 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 8 | 1,714 (0%) | 0% | 616.6 | 4,933 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 16 | 71,384 (0%) | 0% | 616.6 | 9,866 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 616.65 per share. | 16 Oct 2023 | 23 | 15,156 (0%) | 0% | 616.7 | 14,183 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 16 | 1,051 (0%) | 0% | 616.6 | 9,866 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 616.67 per share. | 16 Oct 2023 | 18 | 53,397 (0%) | 0% | 616.7 | 11,100 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 616.62 per share. | 16 Oct 2023 | 16 | 2,197 (0%) | 0% | 616.6 | 9,866 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 571.33 per share. | 18 Sep 2023 | 9 | 1,706 (0%) | 0% | 571.3 | 5,142 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 571.29 per share. | 18 Sep 2023 | 17 | 71,368 (0%) | 0% | 571.3 | 9,712 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 571.28 per share. | 18 Sep 2023 | 25 | 15,133 (0%) | 0% | 571.3 | 14,282 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 571.29 per share. | 18 Sep 2023 | 17 | 1,035 (0%) | 0% | 571.3 | 9,712 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 571.30 per share. | 18 Sep 2023 | 20 | 53,379 (0%) | 0% | 571.3 | 11,426 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 571.29 per share. | 18 Sep 2023 | 17 | 2,181 (0%) | 0% | 571.3 | 9,712 | Common Stock |
Alonzo Weems | EVP, ERM & CECO | 12 Sep 2023 | 760 | 7,000 (0%) | 0% | 0 | Common Stock | ||
Alonzo Weems | EVP, ERM & CECO | 12 Sep 2023 | 1,148 | 7,760 (0%) | 0% | 591.0 | 678,445 | Common Stock | |
Eric Dozier | EVP, HR & Diversity | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2023 | 546 | 6,262 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 550.56 per share. | 21 Aug 2023 | 9 | 1,694 (0%) | 0% | 550.6 | 4,955 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 550.50 per share. | 21 Aug 2023 | 18 | 71,214 (0%) | 0% | 550.5 | 9,909 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 550.50 per share. | 21 Aug 2023 | 26 | 15,079 (0%) | 0% | 550.5 | 14,313 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 550.50 per share. | 21 Aug 2023 | 18 | 1,017 (0%) | 0% | 550.5 | 9,909 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 550.52 per share. | 21 Aug 2023 | 21 | 53,256 (0%) | 0% | 550.5 | 11,561 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 546.51 per share. | 21 Aug 2023 | 600 | 5,378 (0%) | 0% | 546.5 | 327,906 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 550.50 per share. | 21 Aug 2023 | 18 | 2,160 (0%) | 0% | 550.5 | 9,909 | Common Stock |
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2023 | 249 | 105,338 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Aug 2023 | 9,550 | 440,443 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 447.18 per share. | 17 Jul 2023 | 11 | 1,685 (0%) | 0% | 447.2 | 4,919 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 447.14 per share. | 17 Jul 2023 | 22 | 71,196 (0%) | 0% | 447.1 | 9,837 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 447.12 per share. | 17 Jul 2023 | 32 | 15,053 (0%) | 0% | 447.1 | 14,308 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 447.14 per share. | 17 Jul 2023 | 22 | 999 (0%) | 0% | 447.1 | 9,837 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 447.16 per share. | 17 Jul 2023 | 25 | 53,235 (0%) | 0% | 447.2 | 11,179 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 447.14 per share. | 17 Jul 2023 | 22 | 2,142 (0%) | 0% | 447.1 | 9,837 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 451.91 per share. | 20 Jun 2023 | 11 | 1,674 (0%) | 0% | 451.9 | 4,971 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 451.95 per share. | 20 Jun 2023 | 22 | 71,174 (0%) | 0% | 452.0 | 9,943 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 451.94 per share. | 20 Jun 2023 | 32 | 15,021 (0%) | 0% | 451.9 | 14,462 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 451.95 per share. | 20 Jun 2023 | 22 | 977 (0%) | 0% | 452.0 | 9,943 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 451.96 per share. | 20 Jun 2023 | 25 | 53,210 (0%) | 0% | 452.0 | 11,299 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 451.95 per share. | 20 Jun 2023 | 21 | 2,120 (0%) | 0% | 452.0 | 9,491 | Common Stock |
Johna L. Norton | EVP, Global Quality | 14 Jun 2023 | 1,647 | 30,114 (0%) | 0% | 448 | 737,856 | Common Stock | |
Johna L. Norton | EVP, Global Quality | 14 Jun 2023 | 1,647 | 31,761 (0%) | 0% | 444.3 | 731,746 | Common Stock | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Sale of securities on an exchange or to another person at price $ 429.46 per share. | 01 Jun 2023 | 6,000 | 36,941 (0%) | 0% | 429.5 | 2,576,760 | Common Stock |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,300 | 10,694 (0%) | 0% | 0 | Common Stock | |
Diogo Rau | EVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,300 | 6,300 | - | - | Restricted Stock Unit | |
Diogo Rau | EVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 429.46 per share. | 01 Jun 2023 | 2,848 | 7,846 (0%) | 0% | 429.5 | 1,223,102 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 434.55 per share. | 15 May 2023 | 11 | 1,659 (0%) | 0% | 434.5 | 4,780 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 434.52 per share. | 15 May 2023 | 23 | 70,972 (0%) | 0% | 434.5 | 9,994 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 434.52 per share. | 15 May 2023 | 33 | 14,951 (0%) | 0% | 434.5 | 14,339 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 434.52 per share. | 15 May 2023 | 23 | 953 (0%) | 0% | 434.5 | 9,994 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 434.50 per share. | 15 May 2023 | 26 | 53,051 (0%) | 0% | 434.5 | 11,297 | Common Stock |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 435.29 per share. | 15 May 2023 | 600 | 5,978 (0%) | 0% | 435.3 | 261,174 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 434.50 per share. | 15 May 2023 | 22 | 2,094 (0%) | 0% | 434.5 | 9,559 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 372.38 per share. | 17 Apr 2023 | 13 | 1,648 (0%) | 0% | 372.4 | 4,841 | Common Stock |
Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 372.40 per share. | 17 Apr 2023 | 5 | 63,524 (0%) | 0% | 372.4 | 1,862 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 372.33 per share. | 17 Apr 2023 | 27 | 70,949 (0%) | 0% | 372.3 | 10,053 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 372.36 per share. | 17 Apr 2023 | 39 | 14,918 (0%) | 0% | 372.4 | 14,522 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 372.33 per share. | 17 Apr 2023 | 27 | 930 (0%) | 0% | 372.3 | 10,053 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 372.37 per share. | 17 Apr 2023 | 30 | 53,025 (0%) | 0% | 372.4 | 11,171 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 372.35 per share. | 17 Apr 2023 | 26 | 2,072 (0%) | 0% | 372.3 | 9,681 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 15 | 1,635 (0%) | 0% | 333.6 | 5,004 | Common Stock |
Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 333.67 per share. | 20 Mar 2023 | 6 | 63,519 (0%) | 0% | 333.7 | 2,002 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 30 | 70,922 (0%) | 0% | 333.6 | 10,008 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 43 | 14,879 (0%) | 0% | 333.6 | 14,345 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 333.60 per share. | 20 Mar 2023 | 30 | 655 (0%) | 0% | 333.6 | 10,008 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 333.59 per share. | 20 Mar 2023 | 34 | 52,995 (0%) | 0% | 333.6 | 11,342 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 333.59 per share. | 20 Mar 2023 | 29 | 2,046 (0%) | 0% | 333.6 | 9,674 | Common Stock |
Alonzo Weems | EVP, ERM & CECO | 10 Mar 2023 | 1,000 | 8,908 (0%) | 0% | 318.9 | 318,850 | Common Stock | |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,274 | 1,274 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,890 | 27,704 (0%) | 0% | 0 | Common Stock | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,890 | 0 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.22 per share. | 01 Mar 2023 | 843 | 26,861 (0%) | 0% | 311.2 | 262,358 | Common Stock |
Alonzo Weems | EVP, ERM & CECO | 01 Mar 2023 | 793 | 9,908 (0%) | 0% | 311.2 | 246,797 | Common Stock | |
Alonzo Weems | EVP, ERM & CECO | 01 Mar 2023 | 1,779 | 0 | - | - | Restricted Stock Unit | ||
Alonzo Weems | EVP, ERM & CECO | 01 Mar 2023 | 1,779 | 10,701 (0%) | 0% | 0 | Common Stock | ||
Eric Dozier | EVP, HR & Diversity | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.22 per share. | 01 Mar 2023 | 714 | 6,808 (0%) | 0% | 311.2 | 222,211 | Common Stock |
Eric Dozier | EVP, HR & Diversity | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,602 | 0 | - | - | Restricted Stock Unit | |
Eric Dozier | EVP, HR & Diversity | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,602 | 7,522 (0%) | 0% | 0 | Common Stock | |
Donald A. Zakrowski | SVP, Finance, & CAO | Sale of securities on an exchange or to another person at price $ 322.47 per share. | 27 Feb 2023 | 600 | 6,578 (0%) | 0% | 322.5 | 193,482 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 327.53 per share. | 21 Feb 2023 | 15 | 1,614 (0%) | 0% | 327.5 | 4,913 | Common Stock |
Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 6 | 63,456 (0%) | 0% | 327.5 | 1,965 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 30 | 70,639 (0%) | 0% | 327.5 | 9,825 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 44 | 14,783 (0%) | 0% | 327.5 | 14,410 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 30 | 623 (0%) | 0% | 327.5 | 9,825 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 327.51 per share. | 21 Feb 2023 | 35 | 52,772 (0%) | 0% | 327.5 | 11,463 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 327.50 per share. | 21 Feb 2023 | 30 | 2,010 (0%) | 0% | 327.5 | 9,825 | Common Stock |
Johna L. Norton | EVP, Global Quality | 17 Feb 2023 | 500 | 33,408 (0%) | 0% | 0 | Common Stock | ||
Jacob S. Van Naarden | EVP and CEO Loxo@Lilly | Payment of exercise price or tax liability using portion of securities received from the company at price $ 335.01 per share. | 16 Feb 2023 | 1,314 | 11,845 (0%) | 0% | 335.0 | 440,203 | Common Stock |
Jacob S. Van Naarden | EVP and CEO Loxo@Lilly | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,785 | 0 | - | - | Restricted Stock Unit | |
Jacob S. Van Naarden | EVP and CEO Loxo@Lilly | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 2,785 | 13,159 (0%) | 0% | 0 | Common Stock | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Sale of securities on an exchange or to another person at price $ 342.76 per share. | 10 Feb 2023 | 2,500 | 60,426 (0%) | 0% | 342.8 | 856,900 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 4,124 | 4,124 | - | - | Restricted Stock Unit | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 8,562 | 62,926 (0%) | 0% | 345.1 | 2,954,917 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Sale of securities on an exchange or to another person at price $ 346.47 per share. | 10 Feb 2023 | 2,500 | 57,926 (0%) | 0% | 346.5 | 866,175 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2023 | 4,200 | 387,543 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 56,208 | 443,751 (0%) | 0% | 345.1 | 19,398,505 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 29,611 | 29,611 | - | - | Restricted Stock Unit | |
Donald A. Zakrowski | SVP, Finance, & CAO | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 1,904 | 7,178 (0%) | 0% | 345.1 | 657,108 | Common Stock |
Jacob S. Van Naarden | EVP and CEO Loxo@Lilly | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 2,407 | 10,374 (0%) | 0% | 345.1 | 830,704 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 9,072 | 22,189 (0%) | 0% | 345.1 | 3,130,929 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 4,442 | 4,442 | - | - | Restricted Stock Unit | |
Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 1,744 | 1,744 | - | - | Restricted Stock Unit | |
Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 3,681 | 31,641 (0%) | 0% | 345.1 | 1,270,387 | Common Stock |
Johna L. Norton | EVP, Global Quality | 10 Feb 2023 | 2,507 | 33,908 (0%) | 0% | 345.1 | 865,216 | Common Stock | |
Johna L. Norton | EVP, Global Quality | 10 Feb 2023 | 1,268 | 1,268 | - | - | Restricted Stock Unit | ||
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 18,388 | 105,587 (0%) | 0% | 345.1 | 6,346,067 | Common Stock |
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 9,941 | 9,941 | - | - | Restricted Stock Unit | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 4,124 | 4,124 | - | - | Restricted Stock Unit | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 7,886 | 42,941 (0%) | 0% | 345.1 | 2,721,616 | Common Stock |
Michael B. Mason | EVP & Pres., Lilly Diabetes | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 8,023 | 39,284 (0%) | 0% | 345.1 | 2,768,898 | Common Stock |
Michael B. Mason | EVP & Pres., Lilly Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 3,490 | 3,490 | - | - | Restricted Stock Unit | |
Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 1,350 | 12,974 (0%) | 0% | 345.1 | 465,912 | Common Stock |
Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 3,702 | 3,702 | - | - | Restricted Stock Unit | |
Edgardo Hernandez | EVP & Pres., Mfg. Operations | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 5,204 | 25,814 (0%) | 0% | 345.1 | 1,796,004 | Common Stock |
Alonzo Weems | EVP, ERM & CECO | 10 Feb 2023 | 2,422 | 8,922 (0%) | 0% | 345.1 | 835,881 | Common Stock | |
Eric Dozier | EVP, HR & Diversity | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 1,820 | 5,920 (0%) | 0% | 345.1 | 628,118 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 3,252 | 54,364 (0%) | 0% | 344.2 | 1,119,176 | Common Stock |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 7,264 | 0 | - | - | Restricted Stock Unit | |
Anne Nobles | EVP & Pres, Lilly Neuroscience | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 7,264 | 57,616 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 47,786 | 413,102 (0%) | 0% | 0 | Common Stock | |
David A. Ricks | Director, President, Chair, and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 47,786 | 0 | - | - | Restricted Stock Unit | |
David A. Ricks | Director, President, Chair, and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 21,359 | 391,743 (0%) | 0% | 344.2 | 7,350,700 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 3,393 | 13,117 (0%) | 0% | 344.2 | 1,167,701 | Common Stock |
Anat Hakim | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 7,646 | 0 | - | - | Restricted Stock Unit | |
Anat Hakim | EVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 7,646 | 16,510 (0%) | 0% | 0 | Common Stock | |
Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 1,438 | 27,960 (0%) | 0% | 344.2 | 494,888 | Common Stock |
Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 3,154 | 29,398 (0%) | 0% | 0 | Common Stock | |
Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 3,154 | 0 | - | - | Restricted Stock Unit | |
Johna L. Norton | EVP, Global Quality | 01 Feb 2023 | 941 | 31,401 (0%) | 0% | 344.1 | 323,845 | Common Stock | |
Johna L. Norton | EVP, Global Quality | 01 Feb 2023 | 2,102 | 32,342 (0%) | 0% | 0 | Common Stock | ||
Johna L. Norton | EVP, Global Quality | 01 Feb 2023 | 2,102 | 0 | - | - | Restricted Stock Unit | ||
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 15,675 | 0 | - | - | Restricted Stock Unit | |
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 7,035 | 87,199 (0%) | 0% | 344.1 | 2,421,095 | Common Stock |
Daniel M. Skovronsky | EVP, CS&MO & Pres., LRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 15,675 | 94,234 (0%) | 0% | 0 | Common Stock | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 6,690 | 38,052 (0%) | 0% | 0 | Common Stock | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 6,690 | 0 | - | - | Restricted Stock Unit | |
Patrik Jonsson | EVP&Pres, LLY Imm, LLY USA&CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 2,997 | 35,055 (0%) | 0% | 344.2 | 1,031,418 | Common Stock |
Michael B. Mason | EVP & Pres., Lilly Diabetes | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 6,690 | 34,196 (0%) | 0% | 0 | Common Stock | |
Michael B. Mason | EVP & Pres., Lilly Diabetes | Payment of exercise price or tax liability using portion of securities received from the company at price $ 344.15 per share. | 01 Feb 2023 | 2,935 | 31,261 (0%) | 0% | 344.1 | 1,010,080 | Common Stock |
Michael B. Mason | EVP & Pres., Lilly Diabetes | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 6,690 | 0 | - | - | Restricted Stock Unit | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 357.71 per share. | 17 Jan 2023 | 14 | 1,599 (0%) | 0% | 357.7 | 5,008 | Common Stock |
Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 357.67 per share. | 17 Jan 2023 | 6 | 63,450 (0%) | 0% | 357.7 | 2,146 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 357.75 per share. | 17 Jan 2023 | 28 | 70,609 (0%) | 0% | 357.8 | 10,017 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 357.75 per share. | 17 Jan 2023 | 40 | 14,738 (0%) | 0% | 357.8 | 14,310 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 357.75 per share. | 17 Jan 2023 | 28 | 593 (0%) | 0% | 357.8 | 10,017 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 357.75 per share. | 17 Jan 2023 | 32 | 52,738 (0%) | 0% | 357.8 | 11,448 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 357.74 per share. | 17 Jan 2023 | 27 | 1,981 (0%) | 0% | 357.7 | 9,659 | Common Stock |
David A. Ricks | Director, President, Chair, and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 32,467 | 365,316 (0%) | 0% | 0 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 357.79 per share. | 19 Dec 2022 | 28 | 1,585 (0%) | 0% | 357.8 | 10,018 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 357.79 per share. | 19 Dec 2022 | 28 | 70,581 (0%) | 0% | 357.8 | 10,018 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 357.77 per share. | 19 Dec 2022 | 39 | 14,698 (0%) | 0% | 357.8 | 13,953 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 357.79 per share. | 19 Dec 2022 | 28 | 565 (0%) | 0% | 357.8 | 10,018 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 357.78 per share. | 19 Dec 2022 | 32 | 52,706 (0%) | 0% | 357.8 | 11,449 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 357.78 per share. | 19 Dec 2022 | 27 | 1,954 (0%) | 0% | 357.8 | 9,660 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 1,056 (0%) | 0% | 361.2 | 9,752 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 1,554 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Jackson P. Tai | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 63,402 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 70,362 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 69,864 (0%) | 0% | 361.2 | 9,752 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 14,622 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 361.18 per share. | 21 Nov 2022 | 39 | 14,124 (0%) | 0% | 361.2 | 14,086 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 332 | 536 (0%) | 0% | 361.2 | 119,908 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 204 (0%) | 0% | 361.2 | 9,752 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 361.16 per share. | 21 Nov 2022 | 31 | 52,033 (0%) | 0% | 361.2 | 11,196 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 52,531 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Katherine Baicker | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 22,095 (0%) | 0% | 361.2 | 179,863 | Common Stock |
William G. Kaelin | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 20,470 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Marschall S. Runge | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 16,087 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Jamere Jackson | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 8,370 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 1,922 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 361.19 per share. | 21 Nov 2022 | 27 | 1,424 (0%) | 0% | 361.2 | 9,752 | Common Stock |
Karen Walker | Director | Grant, award, or other acquisition of securities at price $ 361.17 per share. | 21 Nov 2022 | 498 | 5,514 (0%) | 0% | 361.2 | 179,863 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 332.77 per share. | 17 Oct 2022 | 30 | 1,029 (0%) | 0% | 332.8 | 9,983 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 332.77 per share. | 17 Oct 2022 | 30 | 69,837 (0%) | 0% | 332.8 | 9,983 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 332.76 per share. | 17 Oct 2022 | 42 | 14,085 (0%) | 0% | 332.8 | 13,976 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 332.77 per share. | 17 Oct 2022 | 30 | 177 (0%) | 0% | 332.8 | 9,983 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 332.76 per share. | 17 Oct 2022 | 34 | 52,002 (0%) | 0% | 332.8 | 11,314 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 332.76 per share. | 17 Oct 2022 | 29 | 1,397 (0%) | 0% | 332.8 | 9,650 | Common Stock |
Alonzo Weems | EVP, ERM & CECO | 10 Oct 2022 | 450 | 6,500 (0%) | 0% | 0 | Common Stock | ||
Alonzo Weems | EVP, ERM & CECO | 10 Oct 2022 | 656 | 6,950 (0%) | 0% | 326.2 | 214,007 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 33 | 999 (0%) | 0% | 305.1 | 10,068 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 33 | 69,807 (0%) | 0% | 305.1 | 10,068 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 46 | 14,043 (0%) | 0% | 305.1 | 14,034 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 33 | 147 (0%) | 0% | 305.1 | 10,068 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 305.08 per share. | 19 Sep 2022 | 37 | 51,968 (0%) | 0% | 305.1 | 11,288 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 305.09 per share. | 19 Sep 2022 | 32 | 1,368 (0%) | 0% | 305.1 | 9,763 | Common Stock |
Donald A. Zakrowski | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 301.00 per share. | 01 Sep 2022 | 1,000 | 5,274 (0%) | 0% | 301 | 301,000 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 32 | 963 (0%) | 0% | 313.9 | 10,046 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 32 | 69,560 (0%) | 0% | 313.9 | 10,046 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 313.93 per share. | 15 Aug 2022 | 45 | 13,954 (0%) | 0% | 313.9 | 14,127 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 32 | 114 (0%) | 0% | 313.9 | 10,046 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 36 | 51,771 (0%) | 0% | 313.9 | 11,302 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 313.94 per share. | 15 Aug 2022 | 31 | 1,332 (0%) | 0% | 313.9 | 9,732 | Common Stock |
Jackson P. Tai | Director | Purchase of securities on an exchange or from another person at price $ 304.19 per share. | 12 Aug 2022 | 656 | 62,857 (0%) | 0% | 304.2 | 199,549 | Common Stock |
Alonzo Weems | SVP, ERM & CECO | 10 Aug 2022 | 530 | 7,606 (0%) | 0% | 0 | Common Stock | ||
Alonzo Weems | SVP, ERM & CECO | 10 Aug 2022 | 656 | 8,136 (0%) | 0% | 304.5 | 199,752 | Common Stock | |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 31 | 931 (0%) | 0% | 321.8 | 9,975 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 31 | 69,528 (0%) | 0% | 321.8 | 9,975 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 44 | 13,909 (0%) | 0% | 321.8 | 14,158 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 31 | 82 (0%) | 0% | 321.8 | 9,975 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 35 | 51,735 (0%) | 0% | 321.8 | 11,262 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 321.77 per share. | 18 Jul 2022 | 30 | 1,301 (0%) | 0% | 321.8 | 9,653 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 900 (0%) | 0% | 297.3 | 9,812 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 69,497 (0%) | 0% | 297.3 | 9,812 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 297.34 per share. | 21 Jun 2022 | 47 | 13,865 (0%) | 0% | 297.3 | 13,975 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 51 (0%) | 0% | 297.3 | 9,812 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 297.34 per share. | 21 Jun 2022 | 38 | 51,700 (0%) | 0% | 297.3 | 11,299 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 297.33 per share. | 21 Jun 2022 | 33 | 1,271 (0%) | 0% | 297.3 | 9,812 | Common Stock |
Donald A. Zakrowski | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 313.44 per share. | 01 Jun 2022 | 1,000 | 6,274 (0%) | 0% | 313.4 | 313,440 | Common Stock |
Diogo Rau | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 7,560 | 7,560 (0%) | 0% | 0 | Common Stock | |
Diogo Rau | SVP & CIDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 7,560 | 12,600 | - | - | Restricted Stock Unit | |
Diogo Rau | SVP & CIDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.44 per share. | 01 Jun 2022 | 3,166 | 4,394 (0%) | 0% | 313.4 | 992,351 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 299.39 per share. | 16 May 2022 | 33 | 864 (0%) | 0% | 299.4 | 9,880 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 299.39 per share. | 16 May 2022 | 33 | 69,236 (0%) | 0% | 299.4 | 9,880 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 299.38 per share. | 16 May 2022 | 47 | 13,773 (0%) | 0% | 299.4 | 14,071 | Common Stock |
Mary Lynne Hedley | Director | Grant, award, or other acquisition of securities at price $ 299.39 per share. | 16 May 2022 | 18 | 18 (0%) | 0% | 299.4 | 5,389 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 299.37 per share. | 16 May 2022 | 38 | 51,492 (0%) | 0% | 299.4 | 11,376 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 299.38 per share. | 16 May 2022 | 32 | 1,234 (0%) | 0% | 299.4 | 9,580 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 298.82 per share. | 18 Apr 2022 | 33 | 831 (0%) | 0% | 298.8 | 9,861 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 298.82 per share. | 18 Apr 2022 | 33 | 69,203 (0%) | 0% | 298.8 | 9,861 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 298.81 per share. | 18 Apr 2022 | 42 | 13,726 (0%) | 0% | 298.8 | 12,550 | Common Stock |
Raul Alvarez | Director | Grant, award, or other acquisition of securities at price $ 298.82 per share. | 18 Apr 2022 | 38 | 51,454 (0%) | 0% | 298.8 | 11,355 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 298.81 per share. | 18 Apr 2022 | 32 | 1,202 (0%) | 0% | 298.8 | 9,562 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 289.65 per share. | 21 Mar 2022 | 34 | 798 (0%) | 0% | 289.6 | 9,848 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 289.65 per share. | 21 Mar 2022 | 34 | 69,170 (0%) | 0% | 289.6 | 9,848 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 289.65 per share. | 21 Mar 2022 | 43 | 13,684 (0%) | 0% | 289.7 | 12,455 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 289.64 per share. | 21 Mar 2022 | 39 | 51,416 (0%) | 0% | 289.6 | 11,296 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 289.64 per share. | 21 Mar 2022 | 33 | 1,170 (0%) | 0% | 289.6 | 9,558 | Common Stock |
Patrik Jonsson | SVP&Pres, LLY Imm, LLY USA&CCO | Sale of securities on an exchange or to another person at price $ 277.20 per share. | 17 Mar 2022 | 673 | 31,362 (0%) | 0% | 277.2 | 186,556 | Common Stock |
Marschall S. Runge | Director | Purchase of securities on an exchange or from another person at price $ 246.78 per share. | 01 Mar 2022 | 202 | 15,436 (0%) | 0% | 246.8 | 49,850 | Common Stock |
Anat Hakim | SVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.95 per share. | 01 Mar 2022 | 3,500 | 8,864 (0%) | 0% | 250.0 | 874,825 | Common Stock |
Anat Hakim | SVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 7,929 | 12,364 (0%) | 0% | 0 | Common Stock | |
Anat Hakim | SVP, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 7,929 | 0 | - | - | Restricted Stock Unit | |
Patrik Jonsson | SVP&Pres, LLY Imm, LLY USA&CCO | Sale of securities on an exchange or to another person at price $ 247.56 per share. | 01 Mar 2022 | 675 | 32,035 (0%) | 0% | 247.6 | 167,103 | Common Stock |
Donald A. Zakrowski | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 243.84 per share. | 25 Feb 2022 | 1,660 | 7,274 (0%) | 0% | 243.8 | 404,774 | Common Stock |
Gabrielle Sulzberger | Director | Grant, award, or other acquisition of securities at price $ 239.12 per share. | 22 Feb 2022 | 41 | 761 (0%) | 0% | 239.1 | 9,804 | Common Stock |
Jon Erik Fyrwald | Director | Grant, award, or other acquisition of securities at price $ 239.12 per share. | 22 Feb 2022 | 41 | 68,883 (0%) | 0% | 239.1 | 9,804 | Common Stock |
Juan R. Luciano | Director | Grant, award, or other acquisition of securities at price $ 239.13 per share. | 22 Feb 2022 | 53 | 13,591 (0%) | 0% | 239.1 | 12,674 | Common Stock |
Ralph Alvarez | Director | Grant, award, or other acquisition of securities at price $ 239.13 per share. | 22 Feb 2022 | 47 | 51,189 (0%) | 0% | 239.1 | 11,239 | Common Stock |
Kimberly H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 239.12 per share. | 22 Feb 2022 | 40 | 1,133 (0%) | 0% | 239.1 | 9,565 | Common Stock |
Jacob S. Van Naarden | SVP, CEO LoxoONC, Pres LlyONC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2022 | 5,461 | 0 | - | - | Restricted Stock Unit | |
Jacob S. Van Naarden | SVP, CEO LoxoONC, Pres LlyONC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.84 per share. | 16 Feb 2022 | 2,186 | 7,967 (0%) | 0% | 243.8 | 533,034 | Common Stock |
Jacob S. Van Naarden | SVP, CEO LoxoONC, Pres LlyONC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2022 | 5,461 | 10,153 (0%) | 0% | 0 | Common Stock | |
Ilya Yuffa | SVP & President, LLY Intl | Sale of securities on an exchange or to another person at price $ 237.45 per share. | 15 Feb 2022 | 1,000 | 12,624 (0%) | 0% | 237.5 | 237,450 | Common Stock |
Ilya Yuffa | SVP & President, LLY Intl | Sale of securities on an exchange or to another person at price $ 242.58 per share. | 15 Feb 2022 | 1,000 | 11,624 (0%) | 0% | 242.6 | 242,580 | Common Stock |
Anne Nobles | SVP & Pres-Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 7,264 | 7,264 | - | - | Restricted Stock Unit | |
Anne Nobles | SVP & Pres-Lilly Neuroscience | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 11,348 | 50,352 (0%) | 0% | 243.3 | 2,760,628 | Common Stock |
David A. Ricks | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 47,786 | 47,786 | - | - | Restricted Stock Unit | |
David A. Ricks | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 68,004 | 467,783 (0%) | 0% | 243.3 | 16,543,333 | Common Stock |
Donald A. Zakrowski | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 2,947 | 8,934 (0%) | 0% | 243.3 | 716,917 | Common Stock |
Leigh Ann Pusey | SVP, Corp. Affairs & Comm. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 3,154 | 3,154 | - | - | Restricted Stock Unit | |
Leigh Ann Pusey | SVP, Corp. Affairs & Comm. | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 5,309 | 26,244 (0%) | 0% | 243.3 | 1,291,520 | Common Stock |
Johna L. Norton | Senior VP, Global Quality | 09 Feb 2022 | 3,294 | 30,240 (0%) | 0% | 243.3 | 801,331 | Common Stock | |
Johna L. Norton | Senior VP, Global Quality | 09 Feb 2022 | 2,102 | 2,102 | - | - | Restricted Stock Unit | ||
Daniel M. Skovronsky | SVP, CS&MO & Pres. LRL | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 22,581 | 78,559 (0%) | 0% | 243.3 | 5,493,280 | Common Stock |
Daniel M. Skovronsky | SVP, CS&MO & Pres. LRL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 15,675 | 15,675 | - | - | Restricted Stock Unit | |
Ilya Yuffa | SVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 3,275 | 13,624 (0%) | 0% | 243.3 | 796,709 | Common Stock |